Key facts
- This page summarizes Thomas W. Burnell's Form 4 filing for INTERPACE BIOSCIENCES, INC. (IDXG).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 25 May 2021, 17:25.
Thomas W. Burnell - 21 May 2021 Form 4 Insider Report for INTERPACE BIOSCIENCES, INC. (IDXG)
- Reporting relationship
- President & CEO, Director
- Issuer ticker
- IDXG
- Reported as of
- 21 May 2021
- Net transaction value
- +$94,221
- Reporting owner signature
- By: /s/ Thomas W. Burnell
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Thomas W. Burnell filed Form 4 for INTERPACE BIOSCIENCES, INC. (IDXG) on 25 May 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: +$94,221.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
IDXG
transaction
Common Stock
Purchase
- Transaction value
- $94,221
- Shares
- +10,855
- Change %
- Price
- $8.68*
- Shares after
- 10,855
- Date
- 21 May 2021
- Ownership
- By: Spouse
- Footnotes
- F1, F2
IDXG
holding
Restricted Stock Units
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 225,000
- Date
- 21 May 2021
- Ownership
- Direct
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
- The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $8.17 to $8.80. The Reporting Person undertakes to provide Interpace Biosciences, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
Footnote F2
- These shares are owned by Mr. Burnell's spouse. Mr. Burnell disclaims beneficial ownership of these shares.